Skip to main content

Advertisement

Table 2 Baseline clinical and immunological status of Children on ART at Felege Hiwot referral hospital, January 1 st , 2006 - March 31 st , 2011

From: Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: A retrospective follow up study

Variable Frequency Percent (%)
ART eligibility criteria   
  WHO clinical stage   9 1.6
  Immunological/CD4Count   35 6.4
  Both clinical and immunologic   505 92.0
Type of drug at initiation of therapy   
  4a(d4T-3TC-NVP)   208 37.9
  4b(d4T-3TC-EFV)   37 6.7
  4c(AZT-3TC-NVP)   258 47.0
  4d(AZT-3TC-EFV)   43 7.8
  Kaletra based   3 0.6
Regimen change during follow up   
  Yes   68 12.5
  No   475 87.5
Absolute CD4 count   
  CD4 count below the threshold   289 52.6
  CD4 count above the threshold   260 47.4
Developmental History   
  Appropriate   531 96.7
  Delayed   9 1.6
  Regressing   9 1.6
Cotrimoxazole preventive therapy   
  Yes   287 52.3
  No   262 47.7
Nutritional status   
  Underweight   453 82.5
  Normal   92 16.8
  Overweight   4 0.7
WHO clinical staging   
  I   45 8.2
  II   128 23.3
  III   317 57.7
  IV   59 10.7
Haemoglobin(520)   
  <10gm/dl   103 19.8
  ≥10gm/dl   417 80.2
3 rd month ART drug adherence (497)   
  Good   491 98.8
  Fair   3 0.6
  Poor   3 0.6
OIs during follow up   
  Yes   165 30.1
  No   384 69.9
Side effect during follow up(526)   
  Yes   49 8.9
  No   477 86.9